Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
St. John's Wort in Raynaud's Phenomenon
NCT00351117Phase 3Completed
- Start
- Mar 2007
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Raynaud's phenomenon (RP) comparing St. John's Wort with Placebo (2 arms). Primary endpoints: Frequency of Raynaud's Phenomenon attacks at 6 weeks, Duration of Raynaud's Phenomenon attacks at 6 weeks and 1 more. Started Mar 2007; status: completed.
02
Drugs
hypericum perforatum
03
Conditions
Raynaud's phenomenon (RP)
Beyond the preview
Go deeper on NCT00351117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00351117.